These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23551672)

  • 1. Prevention and treatment of cardiovascular disease in women: the obstetric-gynecologist's point of view.
    Perrone G; Brunelli R
    Ther Apher Dial; 2013 Apr; 17(2):162-8. PubMed ID: 23551672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is cardiovascular disease in women inevitable?: preparing for menopause and beyond.
    Johannes J; Bairey Merz CN
    Cardiol Rev; 2011; 19(2):76-80. PubMed ID: 21285667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on cardiovascular disease prevention in women.
    Caboral MF
    Am J Nurs; 2013 Mar; 113(3):26-33; quiz 33, 44. PubMed ID: 23411578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone replacement therapy and cardiovascular risk in menopausal women].
    Simon T; Jaillon P
    Arch Mal Coeur Vaiss; 2001 Feb; 94(2):132-8. PubMed ID: 11265551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing cardiovascular disease in women.
    Hayes SN
    Am Fam Physician; 2006 Oct; 74(8):1331-40. PubMed ID: 17087427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in menopause: does the obstetric history have any bearing?
    Mahendru AA; Morris E
    Menopause Int; 2013 Sep; 19(3):115-20. PubMed ID: 23940129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juggling Multiple Guidelines: A Woman's Heart in the Balance.
    Wenger NK
    J Womens Health (Larchmt); 2016 Mar; 25(3):213-21. PubMed ID: 26771424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Women and cardiovascular diseases].
    Sannito N; Lovreglio V
    Minerva Cardioangiol; 2002 Apr; 50(2):107-16. PubMed ID: 12032464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cardiovascular disease in women.
    Bavry AA; Limacher MC
    Semin Reprod Med; 2014 Nov; 32(6):447-53. PubMed ID: 25321422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Where do we currently stand with advice on hormone replacement therapy for women?
    Bozkurt B
    Methodist Debakey Cardiovasc J; 2010 Nov-2011 Jan; 6(4):21-5. PubMed ID: 21088655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
    Vitale C; Miceli M; Rosano GM
    Climacteric; 2007 Oct; 10 Suppl 2():16-20. PubMed ID: 17882667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One theoretical framework for cardiovascular disease prevention in women.
    Peterson JA
    J Cardiovasc Nurs; 2012; 27(4):295-302. PubMed ID: 21912271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Representation of women in randomized clinical trials of cardiovascular disease prevention.
    Melloni C; Berger JS; Wang TY; Gunes F; Stebbins A; Pieper KS; Dolor RJ; Douglas PS; Mark DB; Newby LK
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):135-42. PubMed ID: 20160159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.